Vitalhub Corp. (TSE:VHI) Given Consensus Rating of “Buy” by Analysts

Shares of Vitalhub Corp. (TSE:VHI) have been given an average rating of “Buy” by the five brokerages that are presently covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued a report on the stock in the last year is C$12.08.

A number of analysts have commented on the stock. TD Securities upped their price target on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a “buy” rating in a research report on Monday. Canaccord Genuity Group increased their price objective on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research note on Thursday, January 16th. Scotiabank set a C$14.00 price objective on shares of Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Finally, Raymond James set a C$13.50 target price on shares of Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, March 27th.

Vitalhub Price Performance

Shares of TSE VHI opened at C$10.15 on Thursday. Vitalhub has a 1 year low of C$5.80 and a 1 year high of C$12.09. The firm has a market cap of C$549.04 million, a PE ratio of 165.09, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The company has a 50 day simple moving average of C$10.46 and a 200 day simple moving average of C$10.36.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.